TRUST Pivotal Study of Innova Laguna Thrombectomy System Completes Enrollment
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Innova Vascular announces completion of enrollment in TRUST trial
Innova Vascular has announced the completion of patient enrolment in the TRUST pivotal investigational device exemption (IDE) clinical study evaluating the safety and effectiveness of the Laguna thrombectomy system for the treatment of pulmonary embolism (PE). The TRUST study enrolled 107 patients across 17 clinical sites and evaluated the Laguna system—an endovascular platform that combines […] The post Innova Vascular announces completion of e…
Endovascular Today
Cardiac Interventions TodayTRUST Pivotal Study of Innova Laguna Thrombectomy System Completes Enrollment
September 1, 2026—Innova Vascular, Inc. announced the completion of patient enrollment in the TRUST pivotal investigational device exemption clinical study, which is evaluating the safety and effectiveness of the company’s Laguna thrombectomy system for the treatment of pulmonary embolism (PE). The TRUST study enrolled 107 patients across 17 clinical sites. According to Innova, the Laguna system combines aspiration and mechanical clot retrieval …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
